Annual CAPEX
$149.40 K
+$95.20 K+175.65%
31 December 2023
Summary:
BioNexus Gene Lab annual capital expenditures is currently $149.40 thousand, with the most recent change of +$95.20 thousand (+175.65%) on 31 December 2023. During the last 3 years, it has fallen by -$272.20 thousand (-64.56%). BGLC annual CAPEX is now -64.56% below its all-time high of $421.60 thousand, reached on 01 December 2020.BGLC CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$199.20 K
+$197.40 K+10966.67%
30 September 2024
Summary:
BioNexus Gene Lab quarterly capital expenditures is currently $199.20 thousand, with the most recent change of +$197.40 thousand (+10966.67%) on 30 September 2024. Over the past year, it has increased by +$65.20 thousand (+48.66%). BGLC quarterly CAPEX is now -52.72% below its all-time high of $421.30 thousand, reached on 01 December 2020.BGLC Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$223.80 K
+$65.20 K+41.11%
30 September 2024
Summary:
BioNexus Gene Lab TTM capital expenditures is currently $223.80 thousand, with the most recent change of +$65.20 thousand (+41.11%) on 30 September 2024. Over the past year, it has increased by +$58.30 thousand (+35.23%). BGLC TTM CAPEX is now -47.12% below its all-time high of $423.20 thousand, reached on 01 September 2021.BGLC TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +175.7% | +48.7% | +35.2% |
| 3 y3 years | -64.6% | +10000.0% | -47.1% |
| 5 y5 years | +277.3% | +5791.4% | +3826.3% |
BGLC CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.6% | +4568.8% | at high | >+9999.0% | -47.1% | +6893.8% |
| 5 y | 5 years | -64.6% | +4568.8% | -52.7% | +5791.4% | -47.1% | >+9999.0% |
| alltime | all time | -64.6% | +4568.8% | -52.7% | +3788.9% | -47.1% | >+9999.0% |
BioNexus Gene Lab CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $199.20 K(>+9900.0%) | $223.80 K(+41.1%) |
| June 2024 | - | $1800.00(-91.8%) | $158.60 K(-7.4%) |
| Mar 2024 | - | $21.90 K(+2333.3%) | $171.20 K(+14.6%) |
| Dec 2023 | $149.40 K(+175.6%) | $900.00(-99.3%) | $149.40 K(-9.7%) |
| Sept 2023 | - | $134.00 K(+830.6%) | $165.50 K(+370.2%) |
| June 2023 | - | $14.40 K(>+9900.0%) | $35.20 K(+59.3%) |
| Mar 2023 | - | $100.00(-99.4%) | $22.10 K(-59.2%) |
| Dec 2022 | $54.20 K(+1593.8%) | $17.00 K(+359.5%) | $54.20 K(+40.8%) |
| Sept 2022 | - | $3700.00(+184.6%) | $38.50 K(+9.4%) |
| June 2022 | - | $1300.00(-96.0%) | $35.20 K(+1.7%) |
| Mar 2022 | - | $32.20 K(+2376.9%) | $34.60 K(+981.3%) |
| Dec 2021 | $3200.00 | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $1300.00(+225.0%) | $3200.00(-99.2%) |
| Sept 2021 | - | $400.00(-42.9%) | $423.20 K(+0.1%) |
| June 2021 | - | $700.00(-12.5%) | $422.80 K(+0.2%) |
| Mar 2021 | - | $800.00(-99.8%) | $422.10 K(+0.1%) |
| Dec 2020 | $421.60 K(+3193.8%) | $421.30 K(>+9900.0%) | $421.60 K(+5597.3%) |
| Sept 2020 | - | $0.00(0.0%) | $7400.00(+89.7%) |
| June 2020 | - | $0.00(-100.0%) | $3900.00(-360.0%) |
| Mar 2020 | - | $300.00(-95.8%) | -$1500.00(-111.7%) |
| Dec 2019 | $12.80 K(-67.7%) | $7100.00(-302.9%) | $12.80 K(+124.6%) |
| Sept 2019 | - | -$3500.00(-35.2%) | $5700.00(-38.0%) |
| June 2019 | - | -$5400.00(-137.0%) | $9200.00(-37.0%) |
| Mar 2019 | - | $14.60 K | $14.60 K |
| Dec 2018 | $39.60 K | - | - |
FAQ
- What is BioNexus Gene Lab annual capital expenditures?
- What is the all time high annual CAPEX for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual CAPEX year-on-year change?
- What is BioNexus Gene Lab quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly CAPEX year-on-year change?
- What is BioNexus Gene Lab TTM capital expenditures?
- What is the all time high TTM CAPEX for BioNexus Gene Lab?
- What is BioNexus Gene Lab TTM CAPEX year-on-year change?
What is BioNexus Gene Lab annual capital expenditures?
The current annual CAPEX of BGLC is $149.40 K
What is the all time high annual CAPEX for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual capital expenditures is $421.60 K
What is BioNexus Gene Lab annual CAPEX year-on-year change?
Over the past year, BGLC annual capital expenditures has changed by +$95.20 K (+175.65%)
What is BioNexus Gene Lab quarterly capital expenditures?
The current quarterly CAPEX of BGLC is $199.20 K
What is the all time high quarterly CAPEX for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly capital expenditures is $421.30 K
What is BioNexus Gene Lab quarterly CAPEX year-on-year change?
Over the past year, BGLC quarterly capital expenditures has changed by +$65.20 K (+48.66%)
What is BioNexus Gene Lab TTM capital expenditures?
The current TTM CAPEX of BGLC is $223.80 K
What is the all time high TTM CAPEX for BioNexus Gene Lab?
BioNexus Gene Lab all-time high TTM capital expenditures is $423.20 K
What is BioNexus Gene Lab TTM CAPEX year-on-year change?
Over the past year, BGLC TTM capital expenditures has changed by +$58.30 K (+35.23%)